| ASSET | YEAR | % RETURN |
|---|---|---|
Phunware (PHUN) | 2019 | 1,988.36% |
Oxbridge Re Holdings Equity Warrant (OXBRW) | 2019 | 1,000% |
Quipt Home Medical (QIPT) | 2019 | 862.5% |
Microbot Medical (MBOT) | 2019 | 453.33% |
Iveda Solutions (IVDA) | 2019 | 361.54% |
CBAK Energy Technology (CBAT) | 2019 | 268.75% |
OncoCyte (OCX) | 2019 | 246.32% |
Castellum (CTM) | 2019 | 235.57% |
GEE (JOB) | 2019 | 206.25% |
Axsome Therapeutics (AXSM) | 2019 | 198.58% |
CLPS (CLPS) | 2019 | 197.28% |
Eledon Pharmaceuticals (ELDN) | 2019 | 175.64% |
NovaBay Pharmaceuticals (NBY) | 2019 | 165.34% |
Fubotv (FUBO) | 2019 | 159.65% |
Avalon GloboCare (ALBT) | 2019 | 154.93% |
Celldex Therapeutics (CLDX) | 2019 | 153.9% |
Rezolute (RZLT) | 2019 | 140% |
Flotek Industries (FTK) | 2019 | 139.25% |
Ocugen (OCGN) | 2019 | 133.18% |
Boxlight Corp Class A (BOXL) | 2019 | 126.4% |
Fortress Biotech (FBIO) | 2019 | 125% |
Venus Concept (VERO) | 2019 | 114.21% |
VirnetX (VHC) | 2019 | 113.39% |
Checkpoint Therapeutics (CKPT) | 2019 | 111.6% |
Scynexis (SCYX) | 2019 | 104.82% |
